![]() |
RMTI | Rockwell Medical, Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.62 |
Leverage | 44.96% |
Market Cap | $ 52.7m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -464.1k |
Margin | -0.46% |
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.